Cellular immune reactions in patients with bronchogenic carcinoma before and after radio-, chemo- and immunotherapy.
D001500:BCG Vaccine / Q000627:therapeutic use; D002283:Carcinoma, Bronchogenic / Q000276:immunology* / Q000532:radiotherapy / Q000628:therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007111:Immunity, Cellular; D007978:Levamisole / Q000627:therapeutic use; D008213:Lymphocyte Activation; D011379:Prognosis; D014374:Tuberculin Test; D014750:Vincristine / Q000627:therapeutic use
D001500:BCG Vaccine; D007978:Levamisole; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide